Reproductive rights groups across the US are responding to the Supreme Court’s decision to throw out a challenge to how mifepristone is accessed. Nancy Northup, president and CEO of the Center for Reproductive Rights said she felt “both relief and anger about this decision.” She said she was glad the decision had been rejected, but did not believe it should have made it to the Supreme Court in the first place. court, echoing Northup’s sentiment. She also warned that further challenges to anti-abortion rights would arise despite the outcome. “Efforts to second guess the FDA’s scientific judgment and roll back access to mifepristone were based on a sham case that not only lacked standing, but relied on speculative allegations and ideological assertions,” the statement said.